ISR Articles
-
Customer Loyalty In Small Molecule Drug Substance Manufacturing
4/15/2019
In Q4, 2018, ISR surveyed 134 sponsors who outsource drug substance manufacturing for small molecule compounds to gain insight into their CMO loyalty. ISR computes customer loyalty as an index that consists of overall satisfaction, willingness to recommend, and likelihood to use the CMO again.
-
Standing Out In The Crowded Biopharma CDMO Market
3/14/2019
This presentation addresses what motivates drug innovators to outsource, who is involved in service provider selection, and which attributes have the greatest influence on CDMO selection.
-
How Do Experience And Capacity Impact Oral Dose Outsourcing?
2/25/2019
In Q2 2018, ISR asked 44 outsourcers of oral solid dose drug product manufacturing to select from four different reasons that manufacturing may be split between in-house and external resources.
-
Outsourcing Drivers By Company Size
2/25/2019
In Q4 2018, ISR surveyed 121 outsourcers of large molecule drug substance manufacturing to understand their primary reason for working with CMOs for biologic API. The data show respondents from small companies, with an annual R&D spend under $1B, are more likely to use CMOs for all of their manufacturing needs than respondents from large pharma companies (61% vs 24%).
-
Outsourcing Impact Of Focus On Innovative Treatment
11/15/2018
In Q4, 2017, ISR asked a follow-up question to respondents who agreed that their company’s focus on developing new innovative treatments will impact its outsourcing practices.
-
Approaches To CMC Involvement Across Drug Development
9/18/2018
In Q42017, ISR interviewed fifteen tenured CMC professionals at top 50 Pharma companies to learn when during the drug development cycle CMC has its greatest involvement and influence.
-
Benefits Of Using Preferred Providers For Clinical Development Outsourcing
5/22/2018
Results from a Q1 2018 ISR survey of 117 outsourcers at biopharmaceutical sponsors regarding the use and performance of a variety of clinical development outsourcing models.
-
Preferred Pharmaceutical Service Providers Use
11/16/2017
This infographic provides an overview of preferred provider arrangements with research, software, and manufacturing organizations by presenting data on preferred provider use, quantity, and selection drivers.
-
Outsourcing Success Requires Constant Evolution
Industry Standard Research explains how Life Science Leader’s CMO Leadership Awards and market research data can help biopharma companies make more informed CMO selection decisions.
-
Industry Trends In Clinical Development Technology
As electronic data sources become embedded in the clinical development process, discover how systems, processes, files, storage, and approvals are moving away from paper and becoming dependent on technology applications.